World leading developer of Male-Factor Infertility Diagnostics.
15% of the couples are globally affected by infertility. With a 50% decline sperm concentrations in men in the West since early 1970s, male-factor infertility accounts for 20-70% of the global infertility.
Unfortunately, there has been little progress in methods to diagnose male-factor infertility, and 30 – 40% of these cases remain unexplained.
Spermosens aims to empower caregivers and patients alike, helping to understand the cause of male-factor infertility despite seemingly normal sperms.